PDB Short entry for 2VIU HEADER HEMAGGLUTININ 22-DEC-97 2VIU TITLE INFLUENZA VIRUS HEMAGGLUTININ COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEMAGGLUTININ; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 OTHER_DETAILS: BROMELAIN DIGESTED; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HEMAGGLUTININ; COMPND 9 CHAIN: B; COMPND 10 ENGINEERED: YES; COMPND 11 MUTATION: YES; COMPND 12 OTHER_DETAILS: BROMELAIN DIGESTED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: INFLUENZA A VIRUS (A/X-31(H3N2)); SOURCE 3 ORGANISM_TAXID: 132504; SOURCE 4 STRAIN: X31; SOURCE 5 OTHER_DETAILS: A REASSORTANT INFLUENZA STRAIN CONTAINING A/AICHI/68 SOURCE 6 (H3N2) HEMAGGLUTININ; SOURCE 7 MOL_ID: 2; SOURCE 8 ORGANISM_SCIENTIFIC: UNIDENTIFIED INFLUENZA VIRUS; SOURCE 9 ORGANISM_TAXID: 11309; SOURCE 10 STRAIN: X31; SOURCE 11 OTHER_DETAILS: A REASSORTANT INFLUENZA STRAIN CONTAINING A/AICHI/68 SOURCE 12 (H3N2) HEMAGGLUTININ KEYWDS HEMAGGLUTININ, ENVELOPE PROTEIN, GLYCOPROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR T.BIZEBARD,D.FLEURY,B.GIGANT,S.A.WHARTON,J.J.SKEHEL,M.KNOSSOW REVDAT 5 03-NOV-21 2VIU 1 SEQADV HETSYN REVDAT 4 29-JUL-20 2VIU 1 COMPND REMARK HETNAM LINK REVDAT 4 2 1 SITE ATOM REVDAT 3 13-JUL-11 2VIU 1 VERSN REVDAT 2 24-FEB-09 2VIU 1 VERSN REVDAT 1 29-APR-98 2VIU 0 JRNL AUTH D.FLEURY,S.A.WHARTON,J.J.SKEHEL,M.KNOSSOW,T.BIZEBARD JRNL TITL ANTIGEN DISTORTION ALLOWS INFLUENZA VIRUS TO ESCAPE JRNL TITL 2 NEUTRALIZATION. JRNL REF NAT.STRUCT.BIOL. V. 5 119 1998 JRNL REFN ISSN 1072-8368 JRNL PMID 9461077 JRNL DOI 10.1038/NSB0298-119 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH T.BIZEBARD,B.GIGANT,P.RIGOLET,B.RASMUSSEN,O.DIAT,P.BOSECKE, REMARK 1 AUTH 2 S.A.WHARTON,J.J.SKEHEL,M.KNOSSOW REMARK 1 TITL STRUCTURE OF INFLUENZA VIRUS HAEMAGGLUTININ COMPLEXED WITH A REMARK 1 TITL 2 NEUTRALIZING ANTIBODY REMARK 1 REF NATURE V. 376 92 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 REFERENCE 2 REMARK 1 AUTH T.BIZEBARD,R.DANIELS,R.KAHN,B.GOLINELLI-PIMPANEAU, REMARK 1 AUTH 2 J.J.SKEHEL,M.KNOSSOW REMARK 1 TITL REFINED THREE-DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A REMARK 1 TITL 2 MURINE IGGL,<LAMBDA> ANTIBODY REMARK 1 REF ACTA CRYSTALLOGR.,SECT.D V. 50 768 1994 REMARK 1 REFN ISSN 0907-4449 REMARK 1 REFERENCE 3 REMARK 1 AUTH I.A.WILSON,J.J.SKEHEL,D.C.WILEY REMARK 1 TITL STRUCTURE OF THE HAEMAGGLUTININ MEMBRANE GLYCOPROTEIN OF REMARK 1 TITL 2 INFLUENZA VIRUS AT 3 A RESOLUTION REMARK 1 REF NATURE V. 289 366 1981 REMARK 1 REFN ISSN 0028-0836 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.84 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 9.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 36234 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3892 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 109 REMARK 3 SOLVENT ATOMS : 103 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.011 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.00 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.500 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THERE IS ONE MONOMER OF THE TRIMERIC HEMAGGLUTININ MOLECULE REMARK 3 IN THE ASYMMETRIC UNIT. THE MONOMER OF HEMAGGLUTININ REMARK 3 CONSISTS OF TWO CHAINS, IDENTIFIED AS HA1 AND HA2 BY THE REMARK 3 THE DEPOSITORS. CHAINS HA1 AND HA2 HAVE BEEN ASSIGNED REMARK 3 CHAIN IDENTIFIERS *A* AND *B*, RESPECTIVELY. REMARK 4 REMARK 4 2VIU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000178738. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-APR-97 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : LURE REMARK 200 BEAMLINE : DW32 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36234 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR 3.84 REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 66.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 5555 Z,X,Y REMARK 290 6555 Z+1/2,-X+1/2,-Y REMARK 290 7555 -Z+1/2,-X,Y+1/2 REMARK 290 8555 -Z,X+1/2,-Y+1/2 REMARK 290 9555 Y,Z,X REMARK 290 10555 -Y,Z+1/2,-X+1/2 REMARK 290 11555 Y+1/2,-Z+1/2,-X REMARK 290 12555 -Y+1/2,-Z,X+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 72.20000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.20000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 72.20000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.20000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 72.20000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 72.20000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY2 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY1 6 0.000000 0.000000 1.000000 72.20000 REMARK 290 SMTRY2 6 -1.000000 0.000000 0.000000 72.20000 REMARK 290 SMTRY3 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY1 7 0.000000 0.000000 -1.000000 72.20000 REMARK 290 SMTRY2 7 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 1.000000 0.000000 72.20000 REMARK 290 SMTRY1 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY2 8 1.000000 0.000000 0.000000 72.20000 REMARK 290 SMTRY3 8 0.000000 -1.000000 0.000000 72.20000 REMARK 290 SMTRY1 9 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 9 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY3 9 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 10 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 10 0.000000 0.000000 1.000000 72.20000 REMARK 290 SMTRY3 10 -1.000000 0.000000 0.000000 72.20000 REMARK 290 SMTRY1 11 0.000000 1.000000 0.000000 72.20000 REMARK 290 SMTRY2 11 0.000000 0.000000 -1.000000 72.20000 REMARK 290 SMTRY3 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY1 12 0.000000 -1.000000 0.000000 72.20000 REMARK 290 SMTRY2 12 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY3 12 1.000000 0.000000 0.000000 72.20000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 39120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -84.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 0.000000 0.000000 1.000000 -72.20000 REMARK 350 BIOMT2 2 -1.000000 0.000000 0.000000 72.20000 REMARK 350 BIOMT3 2 0.000000 -1.000000 0.000000 144.40000 REMARK 350 BIOMT1 3 0.000000 -1.000000 0.000000 72.20000 REMARK 350 BIOMT2 3 0.000000 0.000000 -1.000000 144.40000 REMARK 350 BIOMT3 3 1.000000 0.000000 0.000000 72.20000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 1 REMARK 465 ASP A 2 REMARK 465 LEU A 3 REMARK 465 PRO A 4 REMARK 465 GLY A 5 REMARK 465 ASN A 6 REMARK 465 ASP A 7 REMARK 465 ASN A 8 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU B 132 CG GLU B 132 CD -0.100 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 110 CA - CB - CG ANGL. DEV. = 18.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 62 -105.01 58.34 REMARK 500 ASN A 96 45.44 -146.78 REMARK 500 CYS A 97 -159.63 -137.18 REMARK 500 VAL A 196 -63.40 67.58 REMARK 500 ARG A 201 145.48 -174.15 REMARK 500 THR A 206 -166.09 -121.15 REMARK 500 CYS A 277 -173.00 -171.58 REMARK 500 GLN A 327 82.91 98.21 REMARK 500 ALA B 5 -71.34 -90.37 REMARK 500 ILE B 56 37.29 -93.51 REMARK 500 LYS B 58 87.47 32.32 REMARK 500 PHE B 63 -102.49 -115.41 REMARK 500 GLN B 65 -128.64 -125.51 REMARK 500 ARG B 127 -123.00 47.82 REMARK 500 TYR B 141 39.56 -71.85 REMARK 500 GLN B 172 -136.21 -147.12 REMARK 500 ILE B 173 -51.33 74.34 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 NAG A 430 REMARK 610 NAG A 441 DBREF 2VIU A 1 328 UNP P03437 HEMA_IAAIC 17 344 DBREF 2VIU B 1 175 UNP P03437 HEMA_IAAIC 346 520 SEQADV 2VIU ILE A 131 UNP P03437 THR 147 ENGINEERED MUTATION SEQRES 1 A 328 GLN ASP LEU PRO GLY ASN ASP ASN SER THR ALA THR LEU SEQRES 2 A 328 CYS LEU GLY HIS HIS ALA VAL PRO ASN GLY THR LEU VAL SEQRES 3 A 328 LYS THR ILE THR ASP ASP GLN ILE GLU VAL THR ASN ALA SEQRES 4 A 328 THR GLU LEU VAL GLN SER SER SER THR GLY LYS ILE CYS SEQRES 5 A 328 ASN ASN PRO HIS ARG ILE LEU ASP GLY ILE ASP CYS THR SEQRES 6 A 328 LEU ILE ASP ALA LEU LEU GLY ASP PRO HIS CYS ASP VAL SEQRES 7 A 328 PHE GLN ASN GLU THR TRP ASP LEU PHE VAL GLU ARG SER SEQRES 8 A 328 LYS ALA PHE SER ASN CYS TYR PRO TYR ASP VAL PRO ASP SEQRES 9 A 328 TYR ALA SER LEU ARG SER LEU VAL ALA SER SER GLY THR SEQRES 10 A 328 LEU GLU PHE ILE THR GLU GLY PHE THR TRP THR GLY VAL SEQRES 11 A 328 ILE GLN ASN GLY GLY SER ASN ALA CYS LYS ARG GLY PRO SEQRES 12 A 328 GLY SER GLY PHE PHE SER ARG LEU ASN TRP LEU THR LYS SEQRES 13 A 328 SER GLY SER THR TYR PRO VAL LEU ASN VAL THR MET PRO SEQRES 14 A 328 ASN ASN ASP ASN PHE ASP LYS LEU TYR ILE TRP GLY ILE SEQRES 15 A 328 HIS HIS PRO SER THR ASN GLN GLU GLN THR SER LEU TYR SEQRES 16 A 328 VAL GLN ALA SER GLY ARG VAL THR VAL SER THR ARG ARG SEQRES 17 A 328 SER GLN GLN THR ILE ILE PRO ASN ILE GLY SER ARG PRO SEQRES 18 A 328 TRP VAL ARG GLY LEU SER SER ARG ILE SER ILE TYR TRP SEQRES 19 A 328 THR ILE VAL LYS PRO GLY ASP VAL LEU VAL ILE ASN SER SEQRES 20 A 328 ASN GLY ASN LEU ILE ALA PRO ARG GLY TYR PHE LYS MET SEQRES 21 A 328 ARG THR GLY LYS SER SER ILE MET ARG SER ASP ALA PRO SEQRES 22 A 328 ILE ASP THR CYS ILE SER GLU CYS ILE THR PRO ASN GLY SEQRES 23 A 328 SER ILE PRO ASN ASP LYS PRO PHE GLN ASN VAL ASN LYS SEQRES 24 A 328 ILE THR TYR GLY ALA CYS PRO LYS TYR VAL LYS GLN ASN SEQRES 25 A 328 THR LEU LYS LEU ALA THR GLY MET ARG ASN VAL PRO GLU SEQRES 26 A 328 LYS GLN THR SEQRES 1 B 175 GLY LEU PHE GLY ALA ILE ALA GLY PHE ILE GLU ASN GLY SEQRES 2 B 175 TRP GLU GLY MET ILE ASP GLY TRP TYR GLY PHE ARG HIS SEQRES 3 B 175 GLN ASN SER GLU GLY THR GLY GLN ALA ALA ASP LEU LYS SEQRES 4 B 175 SER THR GLN ALA ALA ILE ASP GLN ILE ASN GLY LYS LEU SEQRES 5 B 175 ASN ARG VAL ILE GLU LYS THR ASN GLU LYS PHE HIS GLN SEQRES 6 B 175 ILE GLU LYS GLU PHE SER GLU VAL GLU GLY ARG ILE GLN SEQRES 7 B 175 ASP LEU GLU LYS TYR VAL GLU ASP THR LYS ILE ASP LEU SEQRES 8 B 175 TRP SER TYR ASN ALA GLU LEU LEU VAL ALA LEU GLU ASN SEQRES 9 B 175 GLN HIS THR ILE ASP LEU THR ASP SER GLU MET ASN LYS SEQRES 10 B 175 LEU PHE GLU LYS THR ARG ARG GLN LEU ARG GLU ASN ALA SEQRES 11 B 175 GLU GLU MET GLY ASN GLY CYS PHE LYS ILE TYR HIS LYS SEQRES 12 B 175 CYS ASP ASN ALA CYS ILE GLU SER ILE ARG ASN GLY THR SEQRES 13 B 175 TYR ASP HIS ASP VAL TYR ARG ASP GLU ALA LEU ASN ASN SEQRES 14 B 175 ARG PHE GLN ILE LYS GLY MODRES 2VIU ASN A 81 ASN GLYCOSYLATION SITE MODRES 2VIU ASN A 165 ASN GLYCOSYLATION SITE MODRES 2VIU ASN A 285 ASN GLYCOSYLATION SITE MODRES 2VIU ASN B 154 ASN GLYCOSYLATION SITE HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 430 14 HET NAG A 440 14 HET NAG A 441 14 HET NAG A 460 14 HET NAG B 410 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 NAG 7(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 FORMUL 9 HOH *103(H2 O) HELIX 1 1 LEU A 66 LEU A 71 1 6 HELIX 2 2 PRO A 74 PHE A 79 5 6 HELIX 3 3 TYR A 105 SER A 115 1 11 HELIX 4 4 ASN A 188 TYR A 195 1 8 HELIX 5 5 LEU B 38 VAL B 55 1 18 HELIX 6 6 ARG B 76 ASN B 129 1 54 HELIX 7 7 ASN B 146 ARG B 153 1 8 HELIX 8 8 HIS B 159 ARG B 170 1 12 SHEET 1 A 2 THR A 24 VAL A 26 0 SHEET 2 A 2 ILE A 34 VAL A 36 -1 N VAL A 36 O THR A 24 SHEET 1 B 2 ALA A 39 GLU A 41 0 SHEET 2 B 2 LYS A 315 ALA A 317 -1 N LEU A 316 O THR A 40 SHEET 1 C 2 LYS A 50 CYS A 52 0 SHEET 2 C 2 PRO A 273 ASP A 275 1 N PRO A 273 O ILE A 51 SHEET 1 D 3 ILE A 58 ASP A 60 0 SHEET 2 D 3 LEU A 86 GLU A 89 1 N LEU A 86 O LEU A 59 SHEET 3 D 3 SER A 266 ARG A 269 1 N SER A 266 O PHE A 87 SHEET 1 E 3 TYR A 100 VAL A 102 0 SHEET 2 E 3 ARG A 229 VAL A 237 1 N ILE A 230 O ASP A 101 SHEET 3 E 3 LYS A 176 HIS A 184 -1 N HIS A 184 O ARG A 229 SHEET 1 F 2 PHE A 120 THR A 122 0 SHEET 2 F 2 GLY A 256 PHE A 258 -1 N TYR A 257 O ILE A 121 SHEET 1 G 2 LEU A 151 TRP A 153 0 SHEET 2 G 2 ILE A 252 PRO A 254 -1 N ALA A 253 O ASN A 152 SHEET 1 H 4 LEU A 164 PRO A 169 0 SHEET 2 H 4 VAL A 242 GLY A 249 -1 N SER A 247 O LEU A 164 SHEET 3 H 4 ARG A 201 SER A 205 -1 N SER A 205 O VAL A 244 SHEET 4 H 4 GLN A 210 ILE A 213 -1 N ILE A 213 O VAL A 202 SHEET 1 I 3 GLY A 286 ILE A 288 0 SHEET 2 I 3 CYS A 281 THR A 283 -1 N THR A 283 O GLY A 286 SHEET 3 I 3 THR A 301 GLY A 303 -1 N TYR A 302 O ILE A 282 SHEET 1 J 2 SER A 136 ARG A 141 0 SHEET 2 J 2 GLY A 144 GLY A 146 -1 N GLY A 146 O SER A 136 SHEET 1 K 2 TYR B 22 ASN B 28 0 SHEET 2 K 2 GLY B 31 ASP B 37 -1 N ASP B 37 O TYR B 22 SHEET 1 L 2 ALA B 130 GLU B 132 0 SHEET 2 L 2 PHE B 138 ILE B 140 -1 N LYS B 139 O GLU B 131 SSBOND 1 CYS A 14 CYS B 137 1555 1555 2.01 SSBOND 2 CYS A 52 CYS A 277 1555 1555 2.02 SSBOND 3 CYS A 64 CYS A 76 1555 1555 2.01 SSBOND 4 CYS A 97 CYS A 139 1555 1555 2.01 SSBOND 5 CYS A 281 CYS A 305 1555 1555 2.00 SSBOND 6 CYS B 144 CYS B 148 1555 1555 2.02 LINK ND2 ASN A 81 C1 NAG A 440 1555 1555 1.45 LINK ND2 ASN A 165 C1 NAG C 1 1555 1555 1.45 LINK ND2 ASN A 285 C1 NAG A 460 1555 1555 1.46 LINK ND2 ASN B 154 C1 NAG B 410 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.39 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.38 CISPEP 1 ASN A 54 PRO A 55 0 0.77 CRYST1 144.400 144.400 144.400 90.00 90.00 90.00 P 21 3 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.006925 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006925 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006925 0.00000